Clinical Trials · NCT03638778
Research Study Comparing Different Tablets With the Study Medicine Semaglutide in Healthy Men
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 105
- Start date
- Aug 2018
- Locations
- 1 site, Germany
- Primary endpoint
- AUC0-24h,sema,day10, area under the semaglutide plasma concentration time curve from 0 to 24 hours after the 10th dosing